ATE91899T1 - Verwendung eines ornithin-decarboxylateinhibitors zur herstellung eines praeparats fuer die behandlung, zusammen mit lak-zellen und interleukin-2, von tumoren. - Google Patents

Verwendung eines ornithin-decarboxylateinhibitors zur herstellung eines praeparats fuer die behandlung, zusammen mit lak-zellen und interleukin-2, von tumoren.

Info

Publication number
ATE91899T1
ATE91899T1 AT87106439T AT87106439T ATE91899T1 AT E91899 T1 ATE91899 T1 AT E91899T1 AT 87106439 T AT87106439 T AT 87106439T AT 87106439 T AT87106439 T AT 87106439T AT E91899 T1 ATE91899 T1 AT E91899T1
Authority
AT
Austria
Prior art keywords
interleukin
inhibitor
treatment
tumors
manufacture
Prior art date
Application number
AT87106439T
Other languages
English (en)
Inventor
Terry R Bowlin
Sai P Sunkara
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE91899T1 publication Critical patent/ATE91899T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT87106439T 1986-05-06 1987-05-04 Verwendung eines ornithin-decarboxylateinhibitors zur herstellung eines praeparats fuer die behandlung, zusammen mit lak-zellen und interleukin-2, von tumoren. ATE91899T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86016686A 1986-05-06 1986-05-06
EP87106439A EP0248217B1 (de) 1986-05-06 1987-05-04 Verwendung eines Ornithin-Decarboxylate-Inhibitors zur Herstellung eines Präparats für die Behandlung, zusammen mit LAK-Zellen und Interleukin-2, von Tumoren

Publications (1)

Publication Number Publication Date
ATE91899T1 true ATE91899T1 (de) 1993-08-15

Family

ID=25332641

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87106439T ATE91899T1 (de) 1986-05-06 1987-05-04 Verwendung eines ornithin-decarboxylateinhibitors zur herstellung eines praeparats fuer die behandlung, zusammen mit lak-zellen und interleukin-2, von tumoren.

Country Status (6)

Country Link
EP (1) EP0248217B1 (de)
JP (1) JPS62263127A (de)
AT (1) ATE91899T1 (de)
CA (1) CA1318586C (de)
DE (1) DE3786705D1 (de)
PH (1) PH23658A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690915A (en) * 1985-08-08 1987-09-01 The United States Of America As Represented By The Department Of Health And Human Services Adoptive immunotherapy as a treatment modality in humans
US5508031A (en) * 1986-11-21 1996-04-16 Cetus Oncology Corporation Method for treating biological damage using a free-radial scavenger and interleukin-2
ZA903804B (en) * 1989-05-23 1991-03-27 Merrell Dow Pharma A method of potentiating cell-mediated immunity utilizing polyamine derivatives
FR2706255B1 (fr) * 1993-06-17 1995-10-27 Univ Rennes Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques.
FR2706254B1 (fr) * 1993-06-17 1995-08-25 Univ Rennes Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines.
EP3478278B1 (de) * 2016-07-01 2024-06-12 Agency for Science, Technology and Research Verfahren zur bestimmung von akuten oder nicht heilenden wunden

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5651442A (en) * 1979-10-01 1981-05-09 Mitsubishi Chem Ind Ltd Ornithine derivative
US4499072A (en) * 1982-11-29 1985-02-12 Merrell Dow Pharmaceuticals Inc. Process for treating diseases with ODC inhibitors

Also Published As

Publication number Publication date
CA1318586C (en) 1993-06-01
PH23658A (en) 1989-09-27
EP0248217A3 (en) 1989-11-08
DE3786705D1 (de) 1993-09-02
EP0248217B1 (de) 1993-07-28
EP0248217A2 (de) 1987-12-09
JPS62263127A (ja) 1987-11-16

Similar Documents

Publication Publication Date Title
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
ATE89723T1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
ATE63694T1 (de) Beleuchtungsanordnung fuer ein system zur behandlung eines patienten durch photoaktivierung.
ATE95060T1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
AU4312285A (en) Collagen and or fibrinogen as carrier of drugs for their introduction into cellular lesion areas
DE69535328D1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
DE69328910D1 (de) Verwendung von 9-cis-Retinsäure sowie ihre Salze und Ester, zur Behandlung von Epitheltumore
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
EP0350036A3 (de) Hematoporphyrin zur topischen Anwendung
ATE81984T1 (de) Verwendung von granulozyt-makrophagen-kolonie erregenden faktor zur herstellung eines medikaments zur behandlung von bakterieller krankheiten.
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE330613T1 (de) Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
ATE63815T1 (de) Verwendung von zinn-protoporphyrin und zinnmesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis.
ATE91899T1 (de) Verwendung eines ornithin-decarboxylateinhibitors zur herstellung eines praeparats fuer die behandlung, zusammen mit lak-zellen und interleukin-2, von tumoren.
ATE289816T1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
ATE79254T1 (de) Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen.
ES2107414T3 (es) Utilizacion de interferon-beta humano para la estimulacion de la eritropoyesis.
ATE197545T1 (de) Verwendung von aspirin zur herstellung eines arzneimittels zur verbesserung fer blutperfusion des uterus
ES8304058A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10,14-hexadecapentaenoico.
KR890000108A (ko) 종양 치료용 약제학적 조성물
ES2042529T3 (es) Un procedimiento para preparar una composicion terapeutica combinada de un eliminador de radicales libres o inhibidor metabolico y una proteina biologicamente activa.
ATE128964T1 (de) Anwendung von beta-alethin in zellkultur und therapie.
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
ATE108331T1 (de) Verwendung von tnf zur herstellung eines arzneimittels zur behandlung von psoriasis.